Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Honig

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Clinical Pharmacology and Therapeutics|July 17, 2007
Benefit and risk assessment in drug development and utilization: a role for clinical pharmacologyP Honig
Clinical Pharmacology and Therapeutics|December 23, 2006
The value and future of clinical pharmacologyP Honig
The Journal of Speech Disorders|March 19, 2010
The stutterer acts it outP HONIG
Nature|February 7, 1970
Solid state chemistry and colloid chemistryE P Honig
Clinical Pharmacology and Therapeutics|February 18, 2010
The economics of drug development: a grim reality and a role for clinical pharmacologyP Honig, R Lalonde
The Journal of Allergy and Clinical Immunology|October 6, 1997
Upper gastrointestinal obstruction associated with Claritin-D 24 Hour Extended Release tabletsE Farinas, P Honig
Pharmacoepidemiology and Drug Safety|August 15, 2001
Risk management of marketed drugs: FDA and the interface with the practice of medicineK Uhl, P Honig
Clinical Pharmacology and Therapeutics|July 19, 2017
Affairs of the Heart: Innovation in Cardiovascular Research and DevelopmentP Honig, A Terzic
Clinical Pharmacology and Therapeutics|October 23, 2008
Clinical pharmacology in the era of biotherapeuticsR L Lalonde, P Honig
Clinical Pharmacology and Therapeutics|April 22, 2014
Intelligent pharmaceuticals: beyond the tipping pointP Honig, S-M Huang
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Clinical Pharmacology and Therapeutics|July 17, 2007
Benefit and risk assessment in drug development and utilization: a role for clinical pharmacologyP Honig
Clinical Pharmacology and Therapeutics|December 23, 2006
The value and future of clinical pharmacologyP Honig
The Journal of Speech Disorders|March 19, 2010
The stutterer acts it outP HONIG
Nature|February 7, 1970
Solid state chemistry and colloid chemistryE P Honig
Clinical Pharmacology and Therapeutics|February 18, 2010
The economics of drug development: a grim reality and a role for clinical pharmacologyP Honig, R Lalonde
The Journal of Allergy and Clinical Immunology|October 6, 1997
Upper gastrointestinal obstruction associated with Claritin-D 24 Hour Extended Release tabletsE Farinas, P Honig
Pharmacoepidemiology and Drug Safety|August 15, 2001
Risk management of marketed drugs: FDA and the interface with the practice of medicineK Uhl, P Honig
Clinical Pharmacology and Therapeutics|July 19, 2017
Affairs of the Heart: Innovation in Cardiovascular Research and DevelopmentP Honig, A Terzic
Clinical Pharmacology and Therapeutics|October 23, 2008
Clinical pharmacology in the era of biotherapeuticsR L Lalonde, P Honig
Clinical Pharmacology and Therapeutics|April 22, 2014
Intelligent pharmaceuticals: beyond the tipping pointP Honig, S-M Huang
Pageof 3